Volume 27, Issue 4 - Patient-reported outcomes

Measuring quality of life – theoretical background

Author: Maria Kołtowska-Häggström

Abstract

Download the full article

References

1. The Economist Intelligence Unit’s qualityof- life index. 2005 [cited 2018 Aug 11]. Available from: Available from: https://www.economist.com/media/pdf/ QUALITY_OF_LIFE.pdf.
2. World Health Organization (WHO) 1948 World Health Organization constitution Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference, New York, 19 June – 22 July 1946; signed on 22 July 1946 by the representatives of 61 States (Official Records of the World Health Organization, no. 2, p. 100) and entered into force on 7 April 1948; Basic Documents, Forty-fifth edition, Supplement. October 2006 [cited 2018 Aug 11]. Available from: Available from: http://www.who.int/governance/eb/who _constitution_en.pdf.
3. Berger ML, Bingefors K, Hedblom EC, Pashos CL, Torrance GW, Dix Smith M, editors. Health care, cost, quality and outcomes: ISPOR book of terms. 1st ed. Lawrenceville: International Society for Pharmacoeconomics and Outcomes Research; 2003. Available from: http://
4. Fayers PM, Machin D. Quality of life, assessment, analysis and interpretation. 1st ed. Chichester, New York, Weinheim, Brisbane, Singapore, Toronto: John Wiley and Sons Ltd; 2001. Available from: http://
5. Kind P. Methodological issues in the assessment of quality of life. In: Abs R, Feldt-Rasmussen U, editors. Growth Hormone Deficiency in Adults: 10 Years of KIMS. Oxford: Oxford PharmaGenesis; 2004. p. 189–98. Available from: http://
6. Ware JE, Jr. The status of health assessment. Annu Rev Public Health. 1995;16:327–54. Available from: http://
7. Wilson IB & Cleary PD. Linking clinical variable with health-related quality of life. JAMA. 1995;273(1):59–65. Available from: http://
8. Snyder AR, Parsons JT, Valovich McLeod TC, Curtis Bay R, Michener LA, Sauers EL. Using disablement models and clinical outcomes assessment to enable evidencebased athletic training practice, Part I: Disablement Models. J Athl Train. 2008;43(4):428–36. Available from: http://
9. Calman KC. Quality of life in cancer patients: an hypothesis. J Med Ethics. 1984;10:24–127. Available from: http://
10. Hunt SM, McKenna SP. The QLDS: a scale for the measurement of quality of life in depression. Health Policy. 1992;22:307–19. Available from: http://
11. Galen Research, Measures Database [cited 2018 Aug 12]. Available from: Available from: http://www.galen-research.com/measuresdatabase/
12. Kołtowska-Häggström M, Mattsson AF, Shalet SM. Assessment of quality of life in adult patients with GH deficiency: KIMS contribution to clinical practice and pharmacoeconomic evaluations. Eur J Endocrinol. 2009;161:S51-S64. Available from: http://
13. Hunt SM, McKenna SP, McEwen J, Williams J, Papp E. The Nottingham health profile: subjective health status and medical consultations. Soc Sci Med. 1981;15:221–9. Available from: http://
14. Likert RA. Technique for the measurement of attitudes. Arch Psychol. 1932;140:1–55. Available from: http://
15. Priestman TJ, Baum M. Evaluation of quality of life in patients receiving treatment for advanced breast cancer. Lancet. 1976;1(7965):899–900. Available from: http://
16. Juniper EF, Guyatt GH, Jaeschke R. How to develop and validate a new health-related quality of life instrument. In: Spilker B, editor. Quality of life and pharma - coeconomics in clinical trials. Philadelphia, New York, 2nd ed. Lippincott-Raven Publishers; 1996. Available from: http://
17. Koltowska-Haggstrom M. Quality of life and growth hormone deficiency in adult patients in clinical evaluation and health economic assessment. Pediatr Endocrinol Diab Metab. 2009;15(3)203–9. Available from: http://
18. Woodhouse LJ, Mukherjee A, Shalet SM, Ezzat S. The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults. Endocrine Rev. 2006;27(3): 287–317. Available from: http://